Patents by Inventor Hiroko OOMIYA

Hiroko OOMIYA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for differentiating between lung squamous cell carcinoma and lung adenocarcinoma
    Patent number: 10787711
    Abstract: Provided is an approach for differentially determining the histological type of a lung cancer lesion objectively and rapidly with high accuracy. A method for differentially assessing a lesion in a lung cancer patient as squamous cell carcinoma or adenocarcinoma, comprising a step of measuring an expression level of an expression product of at least one DNA comprising a transcription start site in a biological sample collected from the lesion, wherein the DNA comprises a base at an arbitrary position in the transcription start site and at least one or more bases located immediately downstream thereof in any of nucleotide sequences represented by SEQ ID NOs: 1 to 213, and the transcription start site is a region wherein both ends thereof are defined by the first base and the 101st base counted from the 3? end in any of the nucleotide sequences represented by SEQ ID NOs: 1 to 213.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: September 29, 2020
    Assignees: JUNTENDO EDUCATIONAL FOUNDATION, RIKEN
    Inventors: Kazuya Takamochi, Kenji Suzuki, Tsuyoshi Saito, Kieko Hara, Keiko Mitani, Kaoru Mogushi, Yoshihide Hayashizaki, Masayoshi Ito, Hideya Kawaji, Hiroko Oomiya, Yasunari Yamanaka
  • METHOD FOR DIFFERENTIATING BETWEEN LUNG SQUAMOUS CELL CARCINOMA AND LUNG ADENOCARCINOMA
    Publication number: 20170073766
    Abstract: Provided is an approach for differentially determining the histological type of a lung cancer lesion objectively and rapidly with high accuracy. A method for differentially assessing a lesion in a lung cancer patient as squamous cell carcinoma or adenocarcinoma, comprising a step of measuring an expression level of an expression product of at least one DNA comprising a transcription start site in a biological sample collected from the lesion, wherein the DNA comprises a base at an arbitrary position in the transcription start site and at least one or more bases located immediately downstream thereof in any of nucleotide sequences represented by SEQ ID NOs: 1 to 213, and the transcription start site is a region wherein both ends thereof are defined by the first base and the 101st base counted from the 3? end in any of the nucleotide sequences represented by SEQ ID NOs: 1 to 213.
    Type: Application
    Filed: March 11, 2015
    Publication date: March 16, 2017
    Applicants: JUNTENDO EDUCATIONAL FOUNDATION, RIKEN
    Inventors: Kazuya TAKAMOCHI, Kenji SUZUKI, Tsuyoshi SAITO, Kieko HARA, Keiko MITANI, Kaoru MOGUSHI, Yoshihide HAYASHIZAKI, Masayoshi TO, Hideya KAWAJI, Hiroko OOMIYA, Yasunari YAMANAKA